NVAX Forecast + Trading Strategies



Bearish<—>Bullish



80% Confidence




Bullish Case: Potential FDA approval may drive the stock up as Novavax leverages its unique protein-based technology and global market expansion, backed by high call volume.




Bearish Case: Regulatory hurdles and intense competition may hinder recovery, keeping prices low and causing more volatility despite Novavax's technological advancements.




Potential Outcomes:
  1. FDA approval boosts NVAX 40%.
  2. Regulatory delays persist 35%.
  3. Market skepticism impacts growth 15%.
  4. Unexpected events sway prices 10%.



May 13, 2025


Novavax Forecast

NVAX        Novavax
















Become a more profitable trader with AI optimized trading strategies






×

Chat with NVAX


 Ask any question about NVAX!